Recital 4, Regulation (EU) 2024/2750

In forcesince 25 Oct 2024

On 2 October 2023, the Agency submitted to the Commission its opinion [Opinion of the Biocidal Products Committee of 13 September 2023 on the Union authorisation of ‘LANXESS CMIT/MIT biocidal product family’ (ECHA/BPC/391/2023), https://echa.europa.eu/opinions-on-union-authorisation.], the draft summary of the biocidal product characteristics (‘SPC’) of ‘LANXESS CMIT/MIT biocidal product family’ and the final assessment report on the biocidal product family, in accordance with Article 44(3) of Regulation (EU) No 528/2012.